Fisher & Paykel Healthcare Increases Opportunity And Risk

Fisher & Paykel Healthcare (FPH) continues to execute its strategy, delivering FY15 results which were above expectations. The numbers beat broker estimates largely because of an impressive performance in gross margins. The revenue mix was tilted towards the respiratory and acute care (RAC) division as opposed to obstructive sleep apnea (OSA), where masks growth stood out but flow generators underwhelmed.

Read More